Literature DB >> 23377495

Chronological shifts and changing causes of death after radiotherapy for early-stage oral cancer.

Rina Fujisawa1, Hitoshi Shibuya, Naoki Harata, Keiko Yuasa-Nakagawa, Kazuma Toda, Keiji Hayashi.   

Abstract

BACKGROUND: Following recent improvements in the curability of oral cancer, chronological shifts and changes in the causes of death after treatment have been observed. We conducted a review of the post-treatment causes of death following radiotherapy for oral cancers.
MATERIALS AND METHODS: The medical records of 966 patients with early-stage (stage I and II) oral cancer treated at our institute between 1980 and 2001 were reviewed, and the chronological shifts and changes in the causes of death after radiotherapy were assessed.
RESULTS: Of the 966 patients enrolled in this study, 365 have died to date. Two hundred and eleven patients died of their primary malignancy; 193 of these deaths occurred within 5 years of treatment for the primary oral cancer. The second most frequent cause of death was second primary cancer (n = 90). Twenty-three patients with head and neck cancers and 18 patients with esophageal cancers died within 10 years of radiotherapy, and six patients with lung cancers died after more than 10 years.
CONCLUSION: Within the first 5 years following treatment, the major cause of death was the primary oral cancer. After 5-10 years, a second primary cancer, such as head and neck cancer or esophageal cancer, became the leading cause of death. Over a 10-year period, the proportion of deaths from a second primary cancer in the lung was significant. We have demonstrated that there are chronological shifts and changes in the causes of death following treatment for early-stage oral cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23377495     DOI: 10.1007/s10147-013-0519-8

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  14 in total

1.  Impact of smoking status on clinical outcome in oral cavity cancer patients.

Authors:  Daisuke Kawakita; Satoyo Hosono; Hidemi Ito; Isao Oze; Miki Watanabe; Nobuhiro Hanai; Yasuhisa Hasegawa; Kazuo Tajima; Shingo Murakami; Hideo Tanaka; Keitaro Matsuo
Journal:  Oral Oncol       Date:  2011-10-12       Impact factor: 5.337

2.  Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers.

Authors:  Rajendra I Bhalavat; Umesh M Mahantshetty; Sanjay Tole; Swamidas V Jamema
Journal:  J Cancer Res Ther       Date:  2009 Jul-Sep       Impact factor: 1.805

3.  US mortality rates for oral cavity and pharyngeal cancer by educational attainment.

Authors:  Amy Y Chen; Carol DeSantis; Ahmedin Jemal
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2011-11

4.  Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome.

Authors:  Ian Ganly; Snehal Patel; Jatin Shah
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

5.  Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma.

Authors:  Chung-Jan Kang; Chun-Ta Liao; Chuen Hsueh; Li-Yu Lee; Chien-Yu Lin; Kang-Hsing Fan; Hung-Ming Wang; Shiang-Fu Huang; I-How Chen; Shu-Hang Ng; Chung-Kan Tsao; Yu-Chen Huang; Tzu-Chen Yen
Journal:  Oral Oncol       Date:  2011-08-15       Impact factor: 5.337

6.  Prevalence of esophageal cancer during the pretreatment of hypopharyngeal cancer patients: routinely performed esophagogastroduodenoscopy and FDG-PET/CT findings.

Authors:  Shuichiro Nakaminato; Akira Toriihara; Tomoko Makino; Tatsuyuki Kawano; Seiji Kishimoto; Hitoshi Shibuya
Journal:  Acta Oncol       Date:  2012-01-10       Impact factor: 4.089

7.  Neck node metastasis after successful brachytherapy for early stage tongue carcinoma.

Authors:  Tsuneaki Nakagawa; Hitoshi Shibuya; Ryoichi Yoshimura; Masahiko Miura; Norihiko Okada; Seiji Kishimoto; Mitsuo Amagasa; Ken Omura
Journal:  Radiother Oncol       Date:  2003-08       Impact factor: 6.280

8.  Brachytherapy for stage I & II oral tongue cancer: an analysis of past cases focusing on control and complications.

Authors:  H Shibuya; M Hoshina; M Takeda; S Matsumoto; S Suzuki; N Okada
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-04-30       Impact factor: 7.038

9.  The frequency of a concomitant early esophageal cancer in male patients with oral and oropharyngeal cancer. Screening results using Lugol dye endoscopy.

Authors:  H Ina; H Shibuya; I Ohashi; M Kitagawa
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

10.  The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: short communication.

Authors:  Waseem Jerjes; Tahwinder Upile; Hani Radhi; Aviva Petrie; Jesuloba Abiola; Aidan Adams; Panagiotis Kafas; Jacqueline Callear; Ramin Carbiner; Kartic Rajaram; Colin Hopper
Journal:  Head Neck Oncol       Date:  2012-03-12
View more
  2 in total

1.  Variation in treatment and outcome in the early stage oral cavity squamous cell carcinoma.

Authors:  Darragh S Gogarty; Paul Lennon; Sandra Deady; J Barry O'Sullivan; Orla McArdle; Mary Leader; Patrick Sheahan; James Paul O'Neill
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-23       Impact factor: 2.503

2.  Metachronous second primary malignancy in head and neck cancer patients: is five years of follow-up sufficient?

Authors:  Mohammad Adeel; Moghira Iqbal Siddiqi
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2018-10-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.